\\n\\n
Released this past November, the list is based on data collected from the Web of Science and highlights some of the world’s most influential scientific minds by naming the researchers whose publications over the previous decade have included a high number of Highly Cited Papers placing them among the top 1% most-cited.
\\n\\nWe wish to congratulate all of the researchers named and especially our authors on this amazing accomplishment! We are happy and proud to share in their success!
Note: Edited in March 2021
\\n"}]',published:!0,mainMedia:{caption:"Highly Cited",originalUrl:"/media/original/117"}},components:[{type:"htmlEditorComponent",content:'IntechOpen is proud to announce that 191 of our authors have made the Clarivate™ Highly Cited Researchers List for 2020, ranking them among the top 1% most-cited.
\n\nThroughout the years, the list has named a total of 261 IntechOpen authors as Highly Cited. Of those researchers, 69 have been featured on the list multiple times.
\n\n\n\nReleased this past November, the list is based on data collected from the Web of Science and highlights some of the world’s most influential scientific minds by naming the researchers whose publications over the previous decade have included a high number of Highly Cited Papers placing them among the top 1% most-cited.
\n\nWe wish to congratulate all of the researchers named and especially our authors on this amazing accomplishment! We are happy and proud to share in their success!
Note: Edited in March 2021
\n'}],latestNews:[{slug:"webinar-introduction-to-open-science-wednesday-18-may-1-pm-cest-20220518",title:"Webinar: Introduction to Open Science | Wednesday 18 May, 1 PM CEST"},{slug:"step-in-the-right-direction-intechopen-launches-a-portfolio-of-open-science-journals-20220414",title:"Step in the Right Direction: IntechOpen Launches a Portfolio of Open Science Journals"},{slug:"let-s-meet-at-london-book-fair-5-7-april-2022-olympia-london-20220321",title:"Let’s meet at London Book Fair, 5-7 April 2022, Olympia London"},{slug:"50-books-published-as-part-of-intechopen-and-knowledge-unlatched-ku-collaboration-20220316",title:"50 Books published as part of IntechOpen and Knowledge Unlatched (KU) Collaboration"},{slug:"intechopen-joins-the-united-nations-sustainable-development-goals-publishers-compact-20221702",title:"IntechOpen joins the United Nations Sustainable Development Goals Publishers Compact"},{slug:"intechopen-signs-exclusive-representation-agreement-with-lsr-libros-servicios-y-representaciones-s-a-de-c-v-20211123",title:"IntechOpen Signs Exclusive Representation Agreement with LSR Libros Servicios y Representaciones S.A. de C.V"},{slug:"intechopen-expands-partnership-with-research4life-20211110",title:"IntechOpen Expands Partnership with Research4Life"},{slug:"introducing-intechopen-book-series-a-new-publishing-format-for-oa-books-20210915",title:"Introducing IntechOpen Book Series - A New Publishing Format for OA Books"}]},book:{item:{type:"book",id:"3163",leadTitle:null,fullTitle:"Pathophysiology and Complications of Diabetes Mellitus",title:"Pathophysiology and Complications of Diabetes Mellitus",subtitle:null,reviewType:"peer-reviewed",abstract:"Diabetes mellitus is a complex, progressive disease, which is accompanied by multiple complications. It is a metabolic disorder of the endocrine system and listed among the most common disorders in both developed and developing countries. It has a global metabolic epidemic and it is estimated that the number of people affected by the disease will rise from the current 150 to 230 million by 2025. Hyperglycaemia is a characteristic feature of diabetes mellitus and chronic hyperglycaemia could lead to long-term complications in the eyes, kidneys, nerves, heart and blood vessels. Interestingly, this book examines the pathophysiology and selected complications in diabetes mellitus.",isbn:null,printIsbn:"978-953-51-0833-7",pdfIsbn:"978-953-51-7040-2",doi:"10.5772/3460",price:119,priceEur:129,priceUsd:155,slug:"pathophysiology-and-complications-of-diabetes-mellitus",numberOfPages:138,isOpenForSubmission:!1,isInWos:null,isInBkci:!1,hash:"080b0947d2ff8138b98e24ba04638df4",bookSignature:"Oluwafemi O. Oguntibeju",publishedDate:"November 14th 2012",coverURL:"https://cdn.intechopen.com/books/images_new/3163.jpg",numberOfDownloads:17009,numberOfWosCitations:10,numberOfCrossrefCitations:10,numberOfCrossrefCitationsByBook:1,numberOfDimensionsCitations:24,numberOfDimensionsCitationsByBook:1,hasAltmetrics:0,numberOfTotalCitations:44,isAvailableForWebshopOrdering:!0,dateEndFirstStepPublish:"December 5th 2011",dateEndSecondStepPublish:"January 9th 2012",dateEndThirdStepPublish:"April 14th 2012",dateEndFourthStepPublish:"July 13th 2012",dateEndFifthStepPublish:"August 12th 2012",currentStepOfPublishingProcess:5,indexedIn:"1,2,3,4,5,6",editedByType:"Edited by",kuFlag:!1,featuredMarkup:null,editors:[{id:"32112",title:"Prof.",name:"Oluwafemi",middleName:"Omoniyi",surname:"Oguntibeju",slug:"oluwafemi-oguntibeju",fullName:"Oluwafemi Oguntibeju",profilePictureURL:"https://mts.intechopen.com/storage/users/32112/images/3371_n.jpg",biography:"Prof Oluwafemi.O Oguntibeju is an Associate Professor and Group Leader (Nutrition and Chronic Disease Research Unit) at the Oxidative Stress Research Centre in the Department of Biomedical Sciences, Faculty of Health & Wellness, Cape Peninsula University of Technology Bellville, South Africa. He lectures and supervises postgraduate students and collaborates with national and international scientists. Over the years, he has been involved in the field of nutrition and HIV/AIDS and related-public health issues but more recently on diabetes. He has published over 90 scientific papers in peer-reviewed journals, presented over 30 papers at national and international conferences and reviewed manuscripts for over 30 international scientific journals. He has received various awards such as the Gold Research Excellence Award at his current university. Prof O.O Oguntibeju is a National Research Foundation (NRF) C-rated researcher and holds a master degree in Biochemistry from the University of Ibadan, Nigeria and a doctoral degree in Biomedical Science at the Central University of Technology, Bloemfontein, South Africa. He is a Chartered Scientist (CSci, UK) and Fellow of the Institute of Biomedical Science, London. He enjoys reading and music and he is married to Faustina and has four children.",institutionString:null,position:null,outsideEditionCount:0,totalCites:0,totalAuthoredChapters:"4",totalChapterViews:"0",totalEditedBooks:"3",institution:null}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,coeditorOne:null,coeditorTwo:null,coeditorThree:null,coeditorFour:null,coeditorFive:null,topics:[{id:"1013",title:"Pediatric Endocrinology",slug:"pediatric-endocrinology"}],chapters:[{id:"40618",title:"CNS Complications of Diabetes Mellitus Type 1 (Type 1 Diabetic Encephalopathy)",doi:"10.5772/49990",slug:"cns-complications-of-diabetes-mellitus-type-1-type-1-diabetic-encephalopathy-",totalDownloads:2875,totalCrossrefCites:2,totalDimensionsCites:3,hasAltmetrics:0,abstract:null,signatures:"Shahriar Ahmadpour",downloadPdfUrl:"/chapter/pdf-download/40618",previewPdfUrl:"/chapter/pdf-preview/40618",authors:[{id:"138803",title:"Dr.",name:"Shahriar",surname:"Ahmadpour",slug:"shahriar-ahmadpour",fullName:"Shahriar Ahmadpour"}],corrections:null},{id:"40619",title:"Bio-Chemical Aspects, Pathophysiology of Microalbuminuria and Glycated Hemoglobin in Type 2 Diabetes Mellitus",doi:"10.5772/50398",slug:"bio-chemical-aspects-pathophysiology-of-microalbuminuria-and-glycated-hemoglobin-in-type-2-diabetes-",totalDownloads:2972,totalCrossrefCites:0,totalDimensionsCites:0,hasAltmetrics:0,abstract:null,signatures:"Manjunatha B. K. Goud, Sarsina O. Devi,\nBhavna Nayal and Saidunnisa Begum",downloadPdfUrl:"/chapter/pdf-download/40619",previewPdfUrl:"/chapter/pdf-preview/40619",authors:[{id:"138865",title:"Dr.",name:"Bhavna",surname:"Nayal",slug:"bhavna-nayal",fullName:"Bhavna Nayal"},{id:"142307",title:"Dr.",name:"B.K.Manjunatha",surname:"Goud",slug:"b.k.manjunatha-goud",fullName:"B.K.Manjunatha Goud"},{id:"142308",title:"Mrs.",name:"Oinam Sarsina",surname:"Devi",slug:"oinam-sarsina-devi",fullName:"Oinam Sarsina Devi"},{id:"154372",title:"Dr.",name:"Saidunnisa",surname:"Begum",slug:"saidunnisa-begum",fullName:"Saidunnisa Begum"}],corrections:null},{id:"40641",title:"Type 2 Diabetes, Immunity and Cardiovascular Risk: A Complex Relationship",doi:"10.5772/50611",slug:"type-2-diabetes-immunity-and-cardiovascular-risk-a-complex-relationship",totalDownloads:2586,totalCrossrefCites:3,totalDimensionsCites:6,hasAltmetrics:0,abstract:null,signatures:"Daniela Pedicino, Ada Francesca Giglio, Vincenzo Alessandro Galiffa, Francesco Trotta and Giovanna Liuzzo",downloadPdfUrl:"/chapter/pdf-download/40641",previewPdfUrl:"/chapter/pdf-preview/40641",authors:[{id:"143984",title:"Dr.",name:"Giovanna",surname:"Liuzzo",slug:"giovanna-liuzzo",fullName:"Giovanna Liuzzo"},{id:"159372",title:"Dr.",name:"Daniela",surname:"Pedicino",slug:"daniela-pedicino",fullName:"Daniela Pedicino"},{id:"159373",title:"Dr.",name:"Ada Francesca",surname:"Giglio",slug:"ada-francesca-giglio",fullName:"Ada Francesca Giglio"},{id:"159374",title:"Dr.",name:"Vincenzo Alessandro",surname:"Galiffa",slug:"vincenzo-alessandro-galiffa",fullName:"Vincenzo Alessandro Galiffa"},{id:"159375",title:"Dr.",name:"Francesco",surname:"Trotta",slug:"francesco-trotta",fullName:"Francesco Trotta"}],corrections:null},{id:"40617",title:"Diabetic Nephropathy",doi:"10.5772/50115",slug:"diabetic-nephropathy",totalDownloads:4408,totalCrossrefCites:2,totalDimensionsCites:12,hasAltmetrics:0,abstract:null,signatures:"Božidar Vujičić, Tamara Turk, Željka Crnčević-Orlić, Gordana Đorđević and Sanjin Rački",downloadPdfUrl:"/chapter/pdf-download/40617",previewPdfUrl:"/chapter/pdf-preview/40617",authors:[{id:"150188",title:"Dr.",name:"Bozidar",surname:"Vujicic",slug:"bozidar-vujicic",fullName:"Bozidar Vujicic"}],corrections:null},{id:"40620",title:"Wavelet Image Fusion Approach for Classification of Ultrasound Placenta Complicated by Gestational Diabetes Mellitus",doi:"10.5772/53530",slug:"wavelet-image-fusion-approach-for-classification-of-ultrasound-placenta-complicated-by-gestational-d",totalDownloads:2179,totalCrossrefCites:2,totalDimensionsCites:2,hasAltmetrics:0,abstract:null,signatures:"G. Malathi and V. Shanthi",downloadPdfUrl:"/chapter/pdf-download/40620",previewPdfUrl:"/chapter/pdf-preview/40620",authors:[{id:"149551",title:"Dr.",name:"G",surname:"Malathi",slug:"g-malathi",fullName:"G Malathi"},{id:"167032",title:"Prof.",name:"V",surname:"Shanthi",slug:"v-shanthi",fullName:"V Shanthi"}],corrections:null},{id:"40616",title:"Periodontitis and Diabetes Mellitus",doi:"10.5772/50269",slug:"periodontitis-and-diabetes-mellitus",totalDownloads:1990,totalCrossrefCites:1,totalDimensionsCites:1,hasAltmetrics:0,abstract:null,signatures:"Michal Straka and Michaela Straka-Trapezanlidis",downloadPdfUrl:"/chapter/pdf-download/40616",previewPdfUrl:"/chapter/pdf-preview/40616",authors:[{id:"139467",title:"Dr.",name:"Michal",surname:"Straka",slug:"michal-straka",fullName:"Michal Straka"},{id:"142827",title:"MSc.",name:"Michaela",surname:"Straka Trapezanlidis",slug:"michaela-straka-trapezanlidis",fullName:"Michaela Straka Trapezanlidis"}],corrections:null}],productType:{id:"1",title:"Edited Volume",chapterContentType:"chapter",authoredCaption:"Edited by"},subseries:null,tags:null},relatedBooks:[{type:"book",id:"2666",title:"Diabetes Mellitus",subtitle:"Insights and Perspectives",isOpenForSubmission:!1,hash:"49a714ae0be8a338523befe4ffc9352f",slug:"diabetes-mellitus-insights-and-perspectives",bookSignature:"Oluwafemi O. Oguntibeju",coverURL:"https://cdn.intechopen.com/books/images_new/2666.jpg",editedByType:"Edited by",editors:[{id:"32112",title:"Prof.",name:"Oluwafemi",surname:"Oguntibeju",slug:"oluwafemi-oguntibeju",fullName:"Oluwafemi Oguntibeju"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"3829",title:"Antioxidant-Antidiabetic Agents and Human Health",subtitle:null,isOpenForSubmission:!1,hash:"148f7976e4249aa1f0180cca370e36ce",slug:"antioxidant-antidiabetic-agents-and-human-health",bookSignature:"Oluwafemi Oguntibeju",coverURL:"https://cdn.intechopen.com/books/images_new/3829.jpg",editedByType:"Edited by",editors:[{id:"32112",title:"Prof.",name:"Oluwafemi",surname:"Oguntibeju",slug:"oluwafemi-oguntibeju",fullName:"Oluwafemi Oguntibeju"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"3266",title:"Type 1 Diabetes",subtitle:null,isOpenForSubmission:!1,hash:"21684525ccb8c6acd89bc43ce177f90b",slug:"type-1-diabetes",bookSignature:"Alan P. Escher and Alice Li",coverURL:"https://cdn.intechopen.com/books/images_new/3266.jpg",editedByType:"Edited by",editors:[{id:"46023",title:"Dr.",name:"Alan",surname:"Escher",slug:"alan-escher",fullName:"Alan Escher"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"3857",title:"Glucose Homeostasis",subtitle:null,isOpenForSubmission:!1,hash:"7d6d19b59871b430fbcfc4bd297e242d",slug:"glucose-homeostasis",bookSignature:"Leszek Szablewski",coverURL:"https://cdn.intechopen.com/books/images_new/3857.jpg",editedByType:"Edited by",editors:[{id:"49739",title:"Dr.",name:"Leszek",surname:"Szablewski",slug:"leszek-szablewski",fullName:"Leszek Szablewski"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"665",title:"Global Perspective on Diabetic Foot Ulcerations",subtitle:null,isOpenForSubmission:!1,hash:"b702efe619adff42227dadb5b4bda12b",slug:"global-perspective-on-diabetic-foot-ulcerations",bookSignature:"Thanh Dinh",coverURL:"https://cdn.intechopen.com/books/images_new/665.jpg",editedByType:"Edited by",editors:[{id:"69737",title:"Dr.",name:"Thanh",surname:"Dinh",slug:"thanh-dinh",fullName:"Thanh Dinh"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"1035",title:"Type 1 Diabetes",subtitle:"Complications",isOpenForSubmission:!1,hash:"b7ba654e889d323762cc9fb4a014cdbf",slug:"type-1-diabetes-complications",bookSignature:"David Wagner",coverURL:"https://cdn.intechopen.com/books/images_new/1035.jpg",editedByType:"Edited by",editors:[{id:"45994",title:"Dr.",name:"David",surname:"Wagner",slug:"david-wagner",fullName:"David Wagner"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"1036",title:"Type 1 Diabetes",subtitle:"Complications, Pathogenesis, and Alternative Treatments",isOpenForSubmission:!1,hash:"ccb81d334cd838c9e80f3ebafb63eec0",slug:"type-1-diabetes-complications-pathogenesis-and-alternative-treatments",bookSignature:"Chih-Pin Liu",coverURL:"https://cdn.intechopen.com/books/images_new/1036.jpg",editedByType:"Edited by",editors:[{id:"47141",title:"Prof.",name:"Chih-Pin",surname:"Liu",slug:"chih-pin-liu",fullName:"Chih-Pin Liu"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"3340",title:"Gestational Diabetes",subtitle:"Causes, Diagnosis and Treatment",isOpenForSubmission:!1,hash:"bc0e9aaba958dcee0b00d08175fe4f23",slug:"gestational-diabetes-causes-diagnosis-and-treatment",bookSignature:"Luis Sobrevia",coverURL:"https://cdn.intechopen.com/books/images_new/3340.jpg",editedByType:"Edited by",editors:[{id:"159644",title:"Dr.",name:"Luis",surname:"Sobrevia",slug:"luis-sobrevia",fullName:"Luis Sobrevia"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"1038",title:"Topics in the Prevention, Treatment and Complications of Type 2 Diabetes",subtitle:null,isOpenForSubmission:!1,hash:"fedb4b227715729de998791e200ef56f",slug:"topics-in-the-prevention-treatment-and-complications-of-type-2-diabetes",bookSignature:"Mark B. Zimering",coverURL:"https://cdn.intechopen.com/books/images_new/1038.jpg",editedByType:"Edited by",editors:[{id:"39545",title:"Prof.",name:"Mark",surname:"Zimering",slug:"mark-zimering",fullName:"Mark Zimering"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"337",title:"Gestational Diabetes",subtitle:null,isOpenForSubmission:!1,hash:"893f11fcb95d4ee07b6de7ed120a99c3",slug:"gestational-diabetes",bookSignature:"Miroslav Radenkovic",coverURL:"https://cdn.intechopen.com/books/images_new/337.jpg",editedByType:"Edited by",editors:[{id:"45327",title:"Prof.",name:"Miroslav",surname:"Radenkovic",slug:"miroslav-radenkovic",fullName:"Miroslav Radenkovic"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}}],ofsBooks:[]},correction:{item:{id:"79356",slug:"expression-of-concern-integrated-vehicle-health-management-in-the-automotive-industry",title:"Expression of Concern: Integrated Vehicle Health Management in the Automotive Industry",doi:null,correctionPDFUrl:"https://cdn.intechopen.com/pdfs/79356.pdf",downloadPdfUrl:"/chapter/pdf-download/79356",previewPdfUrl:"/chapter/pdf-preview/79356",totalDownloads:2888,totalCrossrefCites:null,bibtexUrl:"/chapter/bibtex/79356",risUrl:"/chapter/ris/79356",chapter:{id:"11531",slug:"integrated-vehicle-health-management-in-the-automotive-industry",signatures:"Steven Holland",dateSubmitted:null,dateReviewed:null,datePrePublished:null,datePublished:"September 27th 2010",book:{id:"5115",title:"Health Management",subtitle:null,fullTitle:"Health Management",slug:"health-management",publishedDate:"September 27th 2010",bookSignature:"Krzysztof Smigorski",coverURL:"https://cdn.intechopen.com/books/images_new/5115.jpg",licenceType:"CC BY-NC-SA 3.0",editedByType:"Edited by",editors:[{id:"12528",title:"Dr.",name:"Krzysztof",middleName:null,surname:"Smigorski",slug:"krzysztof-smigorski",fullName:"Krzysztof Smigorski"}],productType:{id:"1",title:"Edited Volume",chapterContentType:"chapter",authoredCaption:"Edited by"}},authors:null}},chapter:{id:"11531",slug:"integrated-vehicle-health-management-in-the-automotive-industry",signatures:"Steven Holland",dateSubmitted:null,dateReviewed:null,datePrePublished:null,datePublished:"September 27th 2010",book:{id:"5115",title:"Health Management",subtitle:null,fullTitle:"Health Management",slug:"health-management",publishedDate:"September 27th 2010",bookSignature:"Krzysztof Smigorski",coverURL:"https://cdn.intechopen.com/books/images_new/5115.jpg",licenceType:"CC BY-NC-SA 3.0",editedByType:"Edited by",editors:[{id:"12528",title:"Dr.",name:"Krzysztof",middleName:null,surname:"Smigorski",slug:"krzysztof-smigorski",fullName:"Krzysztof Smigorski"}],productType:{id:"1",title:"Edited Volume",chapterContentType:"chapter",authoredCaption:"Edited by"}},authors:null},book:{id:"5115",title:"Health Management",subtitle:null,fullTitle:"Health Management",slug:"health-management",publishedDate:"September 27th 2010",bookSignature:"Krzysztof Smigorski",coverURL:"https://cdn.intechopen.com/books/images_new/5115.jpg",licenceType:"CC BY-NC-SA 3.0",editedByType:"Edited by",editors:[{id:"12528",title:"Dr.",name:"Krzysztof",middleName:null,surname:"Smigorski",slug:"krzysztof-smigorski",fullName:"Krzysztof Smigorski"}],productType:{id:"1",title:"Edited Volume",chapterContentType:"chapter",authoredCaption:"Edited by"}}},ofsBook:{item:{type:"book",id:"11860",leadTitle:null,title:"Holography - Recent Advances and Applications",subtitle:null,reviewType:"peer-reviewed",abstract:"\r\n\tThe holography of today is in transition from using traditional photo materials to the use of digital cameras and computers. Holography in general and digital holography, in particular, is a broad field developed in the meeting between optics and the digital world of computers. The hologram is a record of an optical pattern, but it usually contains more or different information on the observed scene than a regular image of the same scene. In order to extract the required information from the raw holograms, a digital algorithm is applied according to the specific application of the system. The development of the field has been accelerated lately due to the improvement of digital cameras, computers, and spatial light modulators. As a multidisciplinary area, holography connects experts in electro-optical engineering, image processing, and computer algorithms. More experts are needed when holography is utilized in one of the various applications such as microscopy, industrial inspection, biomedicine, entertainment, and others.
\r\n\r\n\tThis book intends to provide an overview of the world of holography from the aspect of concepts, system architectures, and applications.
",isbn:"978-1-80356-564-4",printIsbn:"978-1-80356-563-7",pdfIsbn:"978-1-80356-565-1",doi:null,price:0,priceEur:0,priceUsd:0,slug:null,numberOfPages:0,isOpenForSubmission:!0,isSalesforceBook:!1,isNomenclature:!1,hash:"dc0d34170f033ec1ab982bd15773bb2d",bookSignature:"Prof. Joseph Rosen",publishedDate:null,coverURL:"https://cdn.intechopen.com/books/images_new/11860.jpg",keywords:"Holographic 3D Display, Holographic Data Storage, Non-imaging Optics, Polarized Holography, Industrial Applications, Machine Learning, Biomedical Applications, Digital Holographic Microscopy, Computer Generated Hologram, Quantitative Phase Imaging, SLM-Based Holography, FINCH",numberOfDownloads:null,numberOfWosCitations:0,numberOfCrossrefCitations:null,numberOfDimensionsCitations:null,numberOfTotalCitations:null,isAvailableForWebshopOrdering:!0,dateEndFirstStepPublish:"March 11th 2022",dateEndSecondStepPublish:"May 11th 2022",dateEndThirdStepPublish:"July 10th 2022",dateEndFourthStepPublish:"September 28th 2022",dateEndFifthStepPublish:"November 27th 2022",dateConfirmationOfParticipation:null,remainingDaysToSecondStep:"16 days",secondStepPassed:!0,areRegistrationsClosed:!1,currentStepOfPublishingProcess:3,editedByType:null,kuFlag:!1,biosketch:"A pioneering researcher in incoherent digital holography and fellow of OPTICA and SPIE with an h-index of 40.",coeditorOneBiosketch:null,coeditorTwoBiosketch:null,coeditorThreeBiosketch:null,coeditorFourBiosketch:null,coeditorFiveBiosketch:null,editors:[{id:"16544",title:"Prof.",name:"Joseph",middleName:null,surname:"Rosen",slug:"joseph-rosen",fullName:"Joseph Rosen",profilePictureURL:"https://mts.intechopen.com/storage/users/16544/images/system/16544.jpg",biography:"Joseph Rosen is a Benjamin H. Swig Professor of Optoelectronics with the School of Electrical and Computer Engineering, Ben-Gurion University of the Negev, Israel. He received his BSc, MSc, and DSc degrees in electrical engineering from the Technion - Israel Institute of Technology in 1984, 1987, and 1992, respectively. He is a fellow of OPTICA (Formerly the Optical Society of America) and the International Society for Optical Engineering (SPIE). His research interests include digital holography, optical microscopy, diffractive optics, interferometry, statistical optics, biomedical optics, optical computing, and image processing. He has co-authored more than 250 book chapters, scientific journal articles, and conference publications.",institutionString:"Ben-Gurion University of the Negev",position:null,outsideEditionCount:0,totalCites:0,totalAuthoredChapters:"1",totalChapterViews:"0",totalEditedBooks:"1",institution:{name:"Ben-Gurion University of the Negev",institutionURL:null,country:{name:"Israel"}}}],coeditorOne:null,coeditorTwo:null,coeditorThree:null,coeditorFour:null,coeditorFive:null,topics:[{id:"20",title:"Physics",slug:"physics"}],chapters:null,productType:{id:"1",title:"Edited Volume",chapterContentType:"chapter",authoredCaption:"Edited by"},personalPublishingAssistant:{id:"429342",firstName:"Zrinka",lastName:"Tomicic",middleName:null,title:"Ms.",imageUrl:"https://mts.intechopen.com/storage/users/429342/images/20008_n.jpg",email:"zrinka@intechopen.com",biography:"As an Author Service Manager, my responsibilities include monitoring and facilitating all publishing activities for authors and editors. From chapter submission and review to approval and revision, copyediting and design, until final publication, I work closely with authors and editors to ensure a simple and easy publishing process. I maintain constant and effective communication with authors, editors and reviewers, which allows for a level of personal support that enables contributors to fully commit and concentrate on the chapters they are writing, editing, or reviewing. I assist authors in the preparation of their full chapter submissions and track important deadlines and ensure they are met. I help to coordinate internal processes such as linguistic review, and monitor the technical aspects of the process. As an ASM I am also involved in the acquisition of editors. Whether that be identifying an exceptional author and proposing an editorship collaboration, or contacting researchers who would like the opportunity to work with IntechOpen, I establish and help manage author and editor acquisition and contact."}},relatedBooks:[{type:"book",id:"58",title:"Holography",subtitle:"Research and Technologies",isOpenForSubmission:!1,hash:null,slug:"holography-research-and-technologies",bookSignature:"Joseph Rosen",coverURL:"https://cdn.intechopen.com/books/images_new/58.jpg",editedByType:"Edited by",editors:[{id:"16544",title:"Prof.",name:"Joseph",surname:"Rosen",slug:"joseph-rosen",fullName:"Joseph Rosen"}],productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"8356",title:"Metastable, Spintronics Materials and Mechanics of Deformable Bodies",subtitle:"Recent Progress",isOpenForSubmission:!1,hash:"1550f1986ce9bcc0db87d407a8b47078",slug:"solid-state-physics-metastable-spintronics-materials-and-mechanics-of-deformable-bodies-recent-progress",bookSignature:"Subbarayan Sivasankaran, Pramoda Kumar Nayak and Ezgi Günay",coverURL:"https://cdn.intechopen.com/books/images_new/8356.jpg",editedByType:"Edited by",editors:[{id:"190989",title:"Dr.",name:"Subbarayan",surname:"Sivasankaran",slug:"subbarayan-sivasankaran",fullName:"Subbarayan Sivasankaran"}],productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"1591",title:"Infrared Spectroscopy",subtitle:"Materials Science, Engineering and Technology",isOpenForSubmission:!1,hash:"99b4b7b71a8caeb693ed762b40b017f4",slug:"infrared-spectroscopy-materials-science-engineering-and-technology",bookSignature:"Theophile Theophanides",coverURL:"https://cdn.intechopen.com/books/images_new/1591.jpg",editedByType:"Edited by",editors:[{id:"37194",title:"Dr.",name:"Theophile",surname:"Theophanides",slug:"theophile-theophanides",fullName:"Theophile Theophanides"}],productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"3161",title:"Frontiers in Guided Wave Optics and Optoelectronics",subtitle:null,isOpenForSubmission:!1,hash:"deb44e9c99f82bbce1083abea743146c",slug:"frontiers-in-guided-wave-optics-and-optoelectronics",bookSignature:"Bishnu Pal",coverURL:"https://cdn.intechopen.com/books/images_new/3161.jpg",editedByType:"Edited by",editors:[{id:"4782",title:"Prof.",name:"Bishnu",surname:"Pal",slug:"bishnu-pal",fullName:"Bishnu Pal"}],productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"3092",title:"Anopheles mosquitoes",subtitle:"New insights into malaria vectors",isOpenForSubmission:!1,hash:"c9e622485316d5e296288bf24d2b0d64",slug:"anopheles-mosquitoes-new-insights-into-malaria-vectors",bookSignature:"Sylvie Manguin",coverURL:"https://cdn.intechopen.com/books/images_new/3092.jpg",editedByType:"Edited by",editors:[{id:"50017",title:"Prof.",name:"Sylvie",surname:"Manguin",slug:"sylvie-manguin",fullName:"Sylvie Manguin"}],productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"371",title:"Abiotic Stress in Plants",subtitle:"Mechanisms and Adaptations",isOpenForSubmission:!1,hash:"588466f487e307619849d72389178a74",slug:"abiotic-stress-in-plants-mechanisms-and-adaptations",bookSignature:"Arun Shanker and B. Venkateswarlu",coverURL:"https://cdn.intechopen.com/books/images_new/371.jpg",editedByType:"Edited by",editors:[{id:"58592",title:"Dr.",name:"Arun",surname:"Shanker",slug:"arun-shanker",fullName:"Arun Shanker"}],productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"72",title:"Ionic Liquids",subtitle:"Theory, Properties, New Approaches",isOpenForSubmission:!1,hash:"d94ffa3cfa10505e3b1d676d46fcd3f5",slug:"ionic-liquids-theory-properties-new-approaches",bookSignature:"Alexander Kokorin",coverURL:"https://cdn.intechopen.com/books/images_new/72.jpg",editedByType:"Edited by",editors:[{id:"19816",title:"Prof.",name:"Alexander",surname:"Kokorin",slug:"alexander-kokorin",fullName:"Alexander Kokorin"}],productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"314",title:"Regenerative Medicine and Tissue Engineering",subtitle:"Cells and Biomaterials",isOpenForSubmission:!1,hash:"bb67e80e480c86bb8315458012d65686",slug:"regenerative-medicine-and-tissue-engineering-cells-and-biomaterials",bookSignature:"Daniel Eberli",coverURL:"https://cdn.intechopen.com/books/images_new/314.jpg",editedByType:"Edited by",editors:[{id:"6495",title:"Dr.",name:"Daniel",surname:"Eberli",slug:"daniel-eberli",fullName:"Daniel Eberli"}],productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"57",title:"Physics and Applications of Graphene",subtitle:"Experiments",isOpenForSubmission:!1,hash:"0e6622a71cf4f02f45bfdd5691e1189a",slug:"physics-and-applications-of-graphene-experiments",bookSignature:"Sergey Mikhailov",coverURL:"https://cdn.intechopen.com/books/images_new/57.jpg",editedByType:"Edited by",editors:[{id:"16042",title:"Dr.",name:"Sergey",surname:"Mikhailov",slug:"sergey-mikhailov",fullName:"Sergey Mikhailov"}],productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"1373",title:"Ionic Liquids",subtitle:"Applications and Perspectives",isOpenForSubmission:!1,hash:"5e9ae5ae9167cde4b344e499a792c41c",slug:"ionic-liquids-applications-and-perspectives",bookSignature:"Alexander Kokorin",coverURL:"https://cdn.intechopen.com/books/images_new/1373.jpg",editedByType:"Edited by",editors:[{id:"19816",title:"Prof.",name:"Alexander",surname:"Kokorin",slug:"alexander-kokorin",fullName:"Alexander Kokorin"}],productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}}]},chapter:{item:{type:"chapter",id:"12337",title:"Magic Mathematics Based on New Matrix Transformations (2D and 3D) for Interdisciplinary Physics, Mathematics, Engineering and Energy Management",doi:"10.5772/10400",slug:"magic-mathematics-based-on-new-matrix-transformations-2d-and-3d-for-interdisciplinary-physics-mathem",body:null,keywords:null,chapterPDFUrl:"https://cdn.intechopen.com/pdfs/12337.pdf",chapterXML:null,downloadPdfUrl:"/chapter/pdf-download/12337",previewPdfUrl:"/chapter/pdf-preview/12337",totalDownloads:7462,totalViews:163,totalCrossrefCites:0,totalDimensionsCites:0,totalAltmetricsMentions:0,impactScore:0,impactScorePercentile:16,impactScoreQuartile:1,hasAltmetrics:0,dateSubmitted:null,dateReviewed:null,datePrePublished:null,datePublished:"November 2nd 2010",dateFinished:null,readingETA:"0",abstract:null,reviewType:"peer-reviewed",bibtexUrl:"/chapter/bibtex/12337",risUrl:"/chapter/ris/12337",book:{id:"3726",slug:"products-and-services--from-r-d-to-final-solutions"},signatures:"Wolfram Stanek and Maralo Sinaga",authors:null,sections:null,chapterReferences:null,footnotes:null,contributors:null,corrections:null},book:{id:"3726",type:"book",title:"Products and Services",subtitle:"from R&D to Final Solutions",fullTitle:"Products and Services; from R&D to Final Solutions",slug:"products-and-services--from-r-d-to-final-solutions",publishedDate:"November 2nd 2010",bookSignature:"Igor Fuerstner",coverURL:"https://cdn.intechopen.com/books/images_new/3726.jpg",licenceType:"CC BY-NC-SA 3.0",editedByType:"Edited by",isbn:null,printIsbn:"978-953-307-211-1",pdfIsbn:"978-953-51-5144-9",reviewType:"peer-reviewed",numberOfWosCitations:36,isAvailableForWebshopOrdering:!0,editors:[{id:"121454",title:"Prof.",name:"Igor",middleName:null,surname:"Fuerstner",slug:"igor-fuerstner",fullName:"Igor Fuerstner"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,coeditorOne:null,coeditorTwo:null,coeditorThree:null,coeditorFour:null,coeditorFive:null,topics:[{id:"442"}],productType:{id:"1",title:"Edited Volume",chapterContentType:"chapter",authoredCaption:"Edited by"},chapters:[{id:"12318",type:"chapter",title:"Large Scale Distributed Knowledge Infrastructures",slug:"large-scale-distributed-knowledge-infrastructures",totalDownloads:2041,totalCrossrefCites:0,signatures:"Wojtek Sylwestrzak",reviewType:"peer-reviewed",authors:[null]},{id:"12319",type:"chapter",title:"Law of Success or Failure in the High Tech Driven Market - 'Revenge of Success' in the Biotech, Nanotech, and ICT Industry",slug:"law-of-success-or-failure-in-the-high-tech-driven-market-and-bio-industry",totalDownloads:3552,totalCrossrefCites:2,signatures:"Makoto Takayama",reviewType:"peer-reviewed",authors:[null]},{id:"12320",type:"chapter",title:"Proactive Crisis Management in Global Manufacturing Operations",slug:"proactive-crisis-management-in-global-manufacturing-operations",totalDownloads:3018,totalCrossrefCites:0,signatures:"Yang Liu and Josu Takala",reviewType:"peer-reviewed",authors:[null]},{id:"12321",type:"chapter",title:"Signals for Emerging Technologies in Paper and Packaging Industry",slug:"signals-for-emerging-technologies-in-paper-and-packaging-industry",totalDownloads:2614,totalCrossrefCites:1,signatures:"Matti Karvonen and Tuomo Kässi",reviewType:"peer-reviewed",authors:[null]},{id:"12322",type:"chapter",title:"Simulation Modelling of Manufacturing Business Systems",slug:"simulation-modelling-of-manufacturing-business-systems",totalDownloads:2815,totalCrossrefCites:0,signatures:"Nenad Perši",reviewType:"peer-reviewed",authors:[null]},{id:"12323",type:"chapter",title:"Project Driven Concurrent Product and Processes Development",slug:"project-driven-concurrent-product-and-processes-development",totalDownloads:4727,totalCrossrefCites:0,signatures:"Janez Kušar, Lidija Rihar, Tomaž Berlec and Marko Starbek",reviewType:"peer-reviewed",authors:[null]},{id:"12324",type:"chapter",title:"Forecasting of Production Order Lead Time in Sme’s",slug:"forecasting-of-production-order-lead-time-in-sme-s",totalDownloads:4388,totalCrossrefCites:2,signatures:"Tomaž Berlec and Marko Starbek",reviewType:"peer-reviewed",authors:[null]},{id:"12325",type:"chapter",title:"The Market for NPD Services: the Emerging Business Models in Italy",slug:"the-market-for-npd-services-the-emerging-business-models-in-italy",totalDownloads:2093,totalCrossrefCites:0,signatures:"Valentina Lazzarotti and Emanuele Pizzurno",reviewType:"peer-reviewed",authors:[null]},{id:"12326",type:"chapter",title:"Process Capability and Six Sigma Methodology Including Fuzzy and Lean Approaches",slug:"process-capability-and-six-sigma-methodology-including-fuzzy-and-lean-approaches",totalDownloads:64469,totalCrossrefCites:9,signatures:"Ozlem Senvar and Hakan Tozan",reviewType:"peer-reviewed",authors:[null]},{id:"12327",type:"chapter",title:"Adaptive Involvement of Customers as Co-Creators in Mass Customization",slug:"adaptive-involvement-of-customers-as-co-creators-in-mass-customization",totalDownloads:1841,totalCrossrefCites:1,signatures:"Igor Fuerstner and Zoran Anišić",reviewType:"peer-reviewed",authors:[null]},{id:"12328",type:"chapter",title:"The Market for Nanotechnology Applications and its Managerial Implications: an Empirical Investigation in the Italian Landscape",slug:"the-market-for-nanotechnology-applications-and-its-managerial-implications-an-empirical-investigatio",totalDownloads:2375,totalCrossrefCites:0,signatures:"Lucio Cassia and Alfredo De Massis",reviewType:"peer-reviewed",authors:[null]},{id:"12329",type:"chapter",title:"Environmental Approaches towards Industrial Company Management in the Czech Republic",slug:"environmental-approaches-towards-industrial-company-management-in-the-czech-republic",totalDownloads:2252,totalCrossrefCites:0,signatures:"Lilia Dvorakova and Tereza Kadlecova",reviewType:"peer-reviewed",authors:[null]},{id:"12330",type:"chapter",title:"Drilling Fluid Technology: Performances and Environmental Considerations",slug:"drilling-fluid-technology-performances-and-environmental-considerations",totalDownloads:34552,totalCrossrefCites:19,signatures:"Mohamed Khodja, Malika Khodja-Saber, Jean Paul Canselier, Nathalie Cohaut and Faïza Bergaya",reviewType:"peer-reviewed",authors:[null]},{id:"12331",type:"chapter",title:"The Advanced Technologies Development Trends for the Raw Material Extraction and Treatment Area",slug:"the-advanced-technologies-development-trends-for-the-raw-material-extraction-and-treatment-area",totalDownloads:2569,totalCrossrefCites:0,signatures:"Ján Spišák and Miroslav Zelko",reviewType:"peer-reviewed",authors:[null]},{id:"12332",type:"chapter",title:"Augmented Reality System for Generating Operation Program of Automobile Assembly System",slug:"augmented-reality-system-for-generating-operation-program-of-automobile-assembly-system",totalDownloads:2719,totalCrossrefCites:0,signatures:"Hong-Seok Park, Jin-Woo Park and Hung-Won Choi",reviewType:"peer-reviewed",authors:[null]},{id:"12333",type:"chapter",title:"Autonomous Evolutionary Algorithm",slug:"autonomous-evolutionary-algorithm",totalDownloads:1638,totalCrossrefCites:1,signatures:"Matej Šprogar",reviewType:"peer-reviewed",authors:[null]},{id:"12334",type:"chapter",title:"Development and Evaluation of the Spoken Dialogue System Based on W3C Recommendations",slug:"development-and-evaluation-of-the-spoken-dialogue-system-based-on-w3c-recommendations",totalDownloads:2415,totalCrossrefCites:0,signatures:"Jozef Juhár and Stanislav Ondáš",reviewType:"peer-reviewed",authors:[null]},{id:"12335",type:"chapter",title:"Adapting Prosody in a Text-to-Speech System",slug:"adapting-prosody-in-a-text-to-speech-system",totalDownloads:2916,totalCrossrefCites:0,signatures:"Janez Stergar and Caglayan Erdem",reviewType:"peer-reviewed",authors:[null]},{id:"12336",type:"chapter",title:"Implementing Innovative IT Solutions with Semantic Web Technologies",slug:"implementing-innovative-it-solutions-with-semantic-web-technologies",totalDownloads:2074,totalCrossrefCites:2,signatures:"Vili Podgorelec and Bostjan Grasic",reviewType:"peer-reviewed",authors:[null]},{id:"12337",type:"chapter",title:"Magic Mathematics Based on New Matrix Transformations (2D and 3D) for Interdisciplinary Physics, Mathematics, Engineering and Energy Management",slug:"magic-mathematics-based-on-new-matrix-transformations-2d-and-3d-for-interdisciplinary-physics-mathem",totalDownloads:7462,totalCrossrefCites:0,signatures:"Wolfram Stanek and Maralo Sinaga",reviewType:"peer-reviewed",authors:[null]},{id:"12338",type:"chapter",title:"Magic Unit Checks for Physics and Extended Field Theory Based on Interdisciplinary Electrodynamics with Applications in Mechatronics and Automation",slug:"magic-unit-checks-for-physics-and-extended-field-theory-based-on-interdisciplinary-electrodynamics-w",totalDownloads:3413,totalCrossrefCites:0,signatures:"Wolfram Stanek, Arko Djajadi and Edward Boris P Manurung",reviewType:"peer-reviewed",authors:[null]}]},relatedBooks:[{type:"book",id:"5331",title:"Advanced Knowledge Application in Practice",subtitle:null,isOpenForSubmission:!1,hash:"a5ca827643b4d112a40af591b31f0e13",slug:"advanced-knowledge-application-in-practice",bookSignature:"Igor Fuerstner",coverURL:"https://cdn.intechopen.com/books/images_new/5331.jpg",editedByType:"Edited by",editors:[{id:"121454",title:"Prof.",name:"Igor",surname:"Fuerstner",slug:"igor-fuerstner",fullName:"Igor Fuerstner"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"},chapters:[{id:"12339",title:"An Advanced and Automated Neural Network Based Textile Defect Detector",slug:"an-advanced-and-automated-neural-network-based-textile-defect-detector-",signatures:"Shamim Akhter and Tamnun E Mursalin",authors:[{id:"13345",title:"Dr.",name:"Pei",middleName:null,surname:"Han",fullName:"Pei Han",slug:"pei-han"}]},{id:"12340",title:"Wear Simulation",slug:"wear-simulation",signatures:"Sören Andersson",authors:[null]},{id:"12341",title:"On-line Optodynamic Monitoring of Laser Materials Processing",slug:"on-line-optodynamic-monitoring-of-laser-materials-processing",signatures:"Janez Diaci and Janez Možina",authors:[null]},{id:"12342",title:"Properties of Hard Carbon Coatings Manufactured on Magnesium Alloys by PACVD Method",slug:"properties-of-hard-carbon-coatings-manufactured-on-magnesium-alloys-by-pacvd-method",signatures:"Marcin Golabczak",authors:[null]},{id:"12343",title:"Simulation of Cold Formability for Cold Forming Processes",slug:"simulation-of-cold-formability-for-cold-forming-processes",signatures:"Seppo Kivivuori",authors:[null]},{id:"12344",title:"Investigation and Comparison of Aluminium Foams Manufactured by Different Techniques",slug:"investigation-and-comparison-of-aluminium-foams-manufactured-by-different-techniques",signatures:"Rossella Surace and Luigi A.C. De Filippis",authors:[null]},{id:"12345",title:"Application of Fractal Dimension for Estimation of the Type of Passenger Car Driver",slug:"application-of-fractal-dimension-for-estimation-of-the-type-of-passenger-car-driver",signatures:"Andrzej Augustynowicz, Hanna Sciegosz and Sebastian Brol",authors:[null]},{id:"12346",title:"Advanced Technologies in Biomechanics Investigations for the Analysis of Human Behaviour in Working Activities",slug:"advanced-technologies-in-biomechanics-investigations-for-the-analysis-of-human-behaviour-in-working-",signatures:"Mihaela Baritz and Diana Cotoros",authors:[null]},{id:"12347",title:"Polar Sport Tester for Cattle Heart Rate Measurements",slug:"polar-sport-tester-for-cattle-heart-rate-measurements",signatures:"Marjan Janzekovic, Peter Vindis, Denis Stajnko and Maksimiljan Brus",authors:[null]},{id:"12348",title:"Realization of a Control IC for PMLSM Drive Based on FPGA Technology",slug:"realization-of-a-control-ic-for-pmlsm-drive-based-on-fpga-technology",signatures:"Ying-Shieh Kung and Chung-Chun Huang",authors:[null]},{id:"12349",title:"Adaptive Control for Power System Stability Improvement",slug:"adaptive-control-for-power-system-stability-improvement",signatures:"Jozef Ritonja",authors:[null]},{id:"12350",title:"General Theory and Practice of Basic Models in The Building of Hydroacoustical Antennas",slug:"general-theory-and-practice-of-basic-models-in-the-building-of-hydroacoustical-antennas",signatures:"Zvonimir Milosic",authors:[null]},{id:"12351",title:"Readout System for Medium-Size Experiments",slug:"readout-system-for-medium-size-experiments",signatures:"Stanislaw Kistryn",authors:[null]},{id:"12352",title:"Swarm Robotics: An Extensive Research Review",slug:"swarm-robotics-an-extensive-research-review",signatures:"Yogeswaran M. and Ponnambalam S. G.",authors:[null]},{id:"12353",title:"Virtual Reality Control Systems",slug:"virtual-reality-control-systems",signatures:"Tomislav Reichenbach, Goran Vasiljevic and Zdenko Kovačić",authors:[null]},{id:"12354",title:"Real-Time Control System for a Two-Wheeled Inverted Pendulum Mobile Robot",slug:"real-time-control-system-for-a-two-wheeled-inverted-pendulum-mobile-robot-",signatures:"Sophan Wahyudi Nawawi",authors:[null]},{id:"12355",title:"From Telerobotic towards Nanorobotic Applications",slug:"from-telerobotic-towards-nanorobotic-applications",signatures:"Riko Safaric and Gregor Skorc",authors:[null]},{id:"12356",title:"Aid for the Blind to Facilitate the Learning Process of the Local Environment by the Use of Tactile Map",slug:"an-aid-for-the-blind-to-facilitate-the-learning-process-of-the-local-environment-by-the-use-of-tacti",signatures:"Rajko Mahkovic",authors:[null]},{id:"12357",title:"Cornea Contour Extraction from OCT Radial Images",slug:"cornea-contour-extraction-from-oct-radial-images",signatures:"Florian Graglia, Jean-Luc Mari and Jean Sequeira",authors:[null]},{id:"12358",title:"Advances in Phytoremediation Research: A Case Study of Gynura Pseudochina (L.) DC.",slug:"advance-in-phytoremediation-research",signatures:"Woranan Nakbanpote, Natthanwoot Paitlertumpai, Kannika Sukadeetad, Orapan Meesungeon and Wattchara Noisa-nguan",authors:[null]}]}],publishedBooks:[{type:"book",id:"1847",title:"Theoretical and Methodological Approaches to Social Sciences and Knowledge Management",subtitle:null,isOpenForSubmission:!1,hash:"76ab953fe7ca1b6e89d7937d69842d5f",slug:"theoretical-and-methodological-approaches-to-social-sciences-and-knowledge-management",bookSignature:"Asunción López-Varela",coverURL:"https://cdn.intechopen.com/books/images_new/1847.jpg",editedByType:"Edited by",editors:[{id:"302731",title:null,name:"Asun",surname:"López-Varela Azcárate",slug:"asun-lopez-varela-azcarate",fullName:"Asun López-Varela Azcárate"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"5753",title:"Intellectual Property Rights",subtitle:null,isOpenForSubmission:!1,hash:"c482cb3d02459eedcb10e874c078f272",slug:"intellectual-property-rights",bookSignature:"Sakthivel Lakshmana Prabu and Timmadonu Narasimman Kuppusami Suriyaprakasha",coverURL:"https://cdn.intechopen.com/books/images_new/5753.jpg",editedByType:"Edited by",editors:[{id:"91590",title:"Dr.",name:"Sakthivel",surname:"Lakshmana Prabu",slug:"sakthivel-lakshmana-prabu",fullName:"Sakthivel Lakshmana Prabu"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"6482",title:"Digital Communication Management",subtitle:null,isOpenForSubmission:!1,hash:"bdc8d07af59256c38e787be4f8242cc0",slug:"digital-communication-management",bookSignature:"Beatriz Peña-Acuña",coverURL:"https://cdn.intechopen.com/books/images_new/6482.jpg",editedByType:"Edited by",editors:[{id:"194887",title:"Dr.",name:"Beatriz",surname:"Peña-Acuña",slug:"beatriz-pena-acuna",fullName:"Beatriz Peña-Acuña"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"6725",title:"Firm Value",subtitle:"Theory and Empirical Evidence",isOpenForSubmission:!1,hash:"df56274854b9ccf88ca5c4b342713671",slug:"firm-value-theory-and-empirical-evidence",bookSignature:"Paolo Saona Hoffmann",coverURL:"https://cdn.intechopen.com/books/images_new/6725.jpg",editedByType:"Edited by",editors:[{id:"201486",title:"Ph.D.",name:"Paolo",surname:"Saona Hoffmann",slug:"paolo-saona-hoffmann",fullName:"Paolo Saona Hoffmann"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}}],publishedBooksByAuthor:[]},onlineFirst:{chapter:{type:"chapter",id:"70907",title:"Extracts and Essential Oils from Medicinal Plants and Their Neuroprotective Effect",doi:"10.5772/intechopen.90903",slug:"extracts-and-essential-oils-from-medicinal-plants-and-their-neuroprotective-effect",body:'\nA number of complementary treatment are currently being investigated to provide neuroprotection or to treat neurodegenerative diseases. Some therapies are known to provide limited benefits because, despite their treating the clinical symptoms, they are not effective in preventing neuronal cell degeneration.
\nThe economic impact of treating neurodegenerative disorders is also high with disproportionately scarce neurological services and resources that patient survival may depend on. Studies have shown that over 80% of natural deaths in low- and middle-income countries may be attributed to stroke [1]. In the United States alone, the combined annual costs of neurological diseases total nearly $ 800 billion, expected to increase in the coming years due to an aging population, resulting in a severe economic burden to the health system [2].
\nRecent advances in understanding the pathophysiological mechanisms of neurological disorders have led to new strategies in drug development. Animal models have contributed considerably to these advances, as they play an important role in evaluating potential drugs that can alleviate these conditions and also delay their processes [3].
\nInterest in natural products has increased significantly, resulting in the increasing use of herbal medicines [4]. In a recent review, Izzo et al. report a 6.8% increase in US herbal and food supplement sales in 2014, with an estimated over $ 6.4 billion in total sales [5].
\nThe clinical and social repercussions of neuropathologies reveal an important theme of study and commitment to structure strategies that can contribute to the quality of life of society. Scientific research has explored which stimuli and substances can contribute to neural cell plasticity, resulting in improved quality of life for people with depression, Alzheimer’s Disease (AD), Parkinson’s Disease (PD), among other nervous system-related disorders [6].
\nIncreased neurogenesis and the facilitating effects of plasticity can be produced by a variety of treatments, including enriched environment, physical activity or drug action [7]. A complementary treatment proposed is the use of herbal medicines, which have scientific relevance in the treatment of neurological diseases because they contain multiple compounds and phytochemicals that can have neuroprotective effect, with a consequent beneficial action for health in different neuropsychiatric and neurodegenerative disorders [8].
\nStudies have investigated therapies that can alleviate the symptoms of neurodegenerative disorders and also avoid the multiple pathogenic factors involved in these diseases. One promising approach is the use of herbal extracts and their isolated bioactive compounds for the treatment of conditions such as Parkinson’s, Alzheimer’s, cerebral ischemia. Behavioral analysis has shown them to have neurochemical activity and symptom reduction [9].
\nRecent advances in understanding the pathophysiological mechanisms related to neurodegenerative diseases point to new strategies in drug development [10]. Animal models have contributed considerably to these advances and play an even greater role in evaluating possible drugs with therapeutic potential, not only to alleviate these pathologies, but also to modify the disease process [3]. Rodents are suitable models for these studies because of their well-characterized brain organization and the magnitude of information focused on altered states of the nervous system [11, 12].
\nPhytotherapics have scientific relevance in the treatment of neurological diseases, as they contain multiple compounds and phytochemicals that can have neuroprotective effects, with consequent beneficial health action between different neuropsychiatric and neurodegenerative disorders [8, 9, 10]. Several extracts that have shown beneficial action in these disorders as will be addressed in this paper.
\nAlzheimer’s disease (AD) is a neurodegenerative pathology that results in progressive loss of cell function, structure and number, leading to widespread brain atrophy and profound cognitive and behavioral deficit [13]. Histopathologically, it is characterized by accumulation of beta-amyloid peptide (ßA), which can initiate a cascade of oxidative events and chronic inflammation leading to neuronal death [14].
\nSeveral studies have investigated the action of
\n
Recent studies, such as Fragoulis et al. have shown that one of the possible explanations for the action of piper mechanism in AD is associated with the activation of the erythroid2-related nuclear factor (NrF2) [15].
\nNrf2 is the major regulator of phase II detoxifying/antioxidant enzymes, including heme oxygenase 1 (HO-1). Transcription factor Nrf2 binds to ARE (antioxidant response element), transcribing a battery of genes involved in redox status, anti-inflammatory response and detoxification [19]. A study by Lobota et al. reports that Nrf2 activation and HO-1 induction are involved in the regulation of inflammation [20].
\nAnother study developed to find agents that activate the Nrf2 factor was performed and three analytically pure kavalactones - Methysticin, Yangonin and Kavain - were researched. The effects of kavalactones on the protection of neural cells against beta-amyloid peptide (ßA)-induced neurotoxicity were evaluated using the ARE-luciferase and Western blot assay. The results indicated that kavalactones Methysticin, Yangonin and Kavain activate time and dose-dependent Nrf2/ARE in astroglial PC-12 and C6 neural C6 cells and thus up-regulate cytoprotective genes. At the same time, viability and cytotoxicity assays have shown that Nrf2 activation is able to protect neuronal cells from neurotoxicity by attenuating neuronal cell death caused by β amyloid [14].
\nTaken together, it is understood that the Nrf2/ARE signaling pathway is an attractive therapeutic target for neurodegenerative diseases and that chemically modified kavalactones as well as naturally occurring kavalactones can attenuate neurological damage by reducing oxidative stress and neuroinflammation.
\nSome herbal medicines have shown neuroprotective effects, such as curcumin, which is the main polyphenol found in turmeric (
Saffron compounds have been linked to beneficial biological properties such as anti-inflammatory, pro-apoptotic, antiproliferative, anti-amyloidogenic, antioxidant, antiviral, and antidiabetic [23, 24]. Saffron’s most bioactive constituents are curcuminoids, including curcumin and its derivatives such as demethoxycurcumin and bisdemetoxycurcumin [25, 26].
\nThe features attributed to curcumin, such as inhibition of amyloid pathology, protection against inflammation and oxidative stress, inhibition of beta amyloid plaque aggregation and tau protein hyperphosphorylation, suggest that this compound may prevent or improve pathological processes related to cognitive decline and dementia, as occur in the symptomatology of AD patients [27, 28].
\nA systematic review study showed that curcumin has a positive action on AD symptoms, both when assessing biochemical and behavioral symptoms. The proposed mechanisms of its action in AD show that it is able to act by preventing the formation and aggregation of β-amyloid protein and tau protein hispanphosphorylation [10], in addition curcumin has also been shown to prevent neural damage, mitochondrial disorders, cellular stress and glial hyperactivation, as shown in Figure 1.
\nActive curcumin mechanisms after experimental treatment in AD models. Curcumin acts by preventing the formation and aggregation of β-amyloid protein and hyperphosphorylation of tau protein, stabilizing microtubules and preventing the formation of neurofibrillary tangles that occur due to deposition of this protein. It has also been shown to prevent mitochondrial damage favoring the increase of cellular ATP and the healthy maintenance of mitochondria, avoiding excessive Ca2+ intake. Curcumin is also able to counteract cellular stress and glial overactivation.
Another compound that represents a promising approach is
The biological and pharmacological properties of AS-IV include its protective effect on pathologies due to its wide range of beneficial actions, such as antioxidant, antibacterial, antiviral [30, 31], anti-inflammatory, anti-asthmatic, antidiabetic, antifibrotic, immunoregulatory and antimicrobial, and cardioprotective effects, preventing myocardial insufficiency in rats [29, 30, 31, 32], able to improve the immune system, digestion and promote wound healing [33].
\nAstragalus action can be understood based on the regulation of the release of caspases and cytochrome c (both being inducers of apoptosis), since cytochrome binds to Apaf-1 and Procaspase-9c when released into cytosol, forming a functional apoptosome and subsequently triggering the sequential activation of caspase-3 and 9 [34]. Several stimuli that induce apoptosis, leading to the release of mitochondrial cytochrome c which plays a key role in a common pathway of caspase activation [34, 35]. In addition, caspase-3 activation has been shown to be a fundamental step in the apoptosis process and its inhibition may block cellular apoptosis.
\nIn addition, Chang et al. evaluated the action of AS-IV on the cerebral cortex after Aβ infusion, showing that i.p. Administration of 40 mg/kg/day of the herbal compound once daily for 14 days reduced the levels of mitochondrial dysfunction apoptosis in cortical cells blocked by inhibition of phosphoinositol 3-kinase (PI3K) protein kinase, known as AKT [36].
\nThe beneficial effects of AS-IV administration in experimental models of neurodegenerative diseases proved to be effective in both in vivo and in vitro models, such as PD and AD, cerebral ischemia and encephalomyelitis by characterizing the antioxidant, antiapoptotic and anti-inflammatory action of this bioactive compound on the various neurochemical substances and behavioral mechanisms. This suggests that the mechanisms presented by AS-IV offer a possible future complementary treatment for the potential treatment of these pathologies [10].
\nParkinson’s disease (PD) is a condition that causes progressive neurodegeneration of dopaminergic neurons with the consequent reduction of dopamine content in the substantia nigra. The 6-hydroxydopamine neurotoxin (6-OHDA) is widely used to mimic the neuropathology of PD [37].
\nThere are reports in the literature analyzing the effect of supplementation, including Chinese herbs and herbal extracts that have shown clinical potential to attenuate the progression of PD in humans. In addition, plant extracts act on the neurochemical or motor profile in isolation [38]. It is known, however, that this pathology involves symptomatology related to both characteristics.
\nA recently published systematic review study discussed studies showing neuroprotective properties of medicinal plants and their bioactive compounds. These included
As previously mentioned, Astragaloside showed a neuroprotective effect on several AD models. In addition, studies have shown the positive action of AS-IV in PD models. One of the studies induced Parkinson by the action of 6-OHDA, where AS IV attenuated the loss of dopaminergic neurons and the treated group presented intact germination, neurite growth and increased immunoreactive TH and NOS. In addition, when the pathology was induced in SH-SY5Y cell culture by MPP + (DP inducing drug) action, it also significantly reversed cell loss, nuclear condensation, intracellular generation of reactive oxygen species and pathway inhibitio
One legume that has become the target of scientific research for its neuroprotective properties is
Another study investigated the ability of guanosine to protect neuronal PC12 cells from toxicity induced by 1-methyl-4-phenylpyridinium (MPP), the active metabolite of 1-methyl-4-phenyl-1, 2, 3, 6-tetrahydropyridine (MPTP), which mediates selective damage to dopaminergic neurons and causes irreversible Parkinson-like symptoms in humans and primates. The results demonstrated that MPP-induced apoptosis of PC12 cells (cell line derived from a rat adrenal membrane pheochromocytoma) was significantly prevented by guanosine pretreatment for 3 h. In addition, guanosine attenuated the collapse of the MPP-induced mitochondrial transmembrane potential and prevented subsequent activation of caspase-3, thus protecting dopaminergic neurons against mitochondrial stress-induced damage [44].
\nOther studies have shown plants with neuroprotective properties capable of protecting from PD damage. These include plants such as
Current PD medications treat symptoms; none prevent or retard the degeneration of dopaminergic neurons. It is understood that the above-mentioned herbal medicines have neuroprotective properties.
\nStroke is the second leading cause of death in industrialized countries and the leading medical cause of acquired adult disability [52].
\n\n
Chang et al. [9] have shown that the use of combined glucose and oxygen administration of guanosine (100 μM) significantly reduced the proportion of apoptosis. To determine whether guanosine was also neuroprotective in vivo, middle cerebral artery occlusion (CoA) was performed in male Wistar rats and guanosine (8 mg/kg) intraperitoneally or saline (control vehicle) was administered daily for 7 days. Guanosine prolongs survival and decreased neurological deficits and tissue damage resulting from CoA. These data are the first to demonstrate that guanosine is neuroprotective in stroke.
\nThrough an experimental study developed by Backhauss and Krieglstein [55] that induced focal cerebral ischemia in rodents, through left middle cerebral artery (MCA) microbipolar coagulation, with the objective of evaluating whether kava extract and its constituents, kawain, dihydrokawain, Methysticin, dihydromethysticin and yangonin, are capable of reducing the size of a heart attack zone in rats and mice, providing protection against ischemic brain damage. Compounds were administered ip, except kava extract, which was administered orally. The results demonstrated that Kava extract decreased the infarct area in mouse brains and the infarct volume in rat brains. Methysticin and dihydromethysticin significantly reduced the infarct area in mouse brain, thus evidencing neuroprotective activity of the mice. Kava extract works by the action of its constituent’s methysticin and dihydromethysticin. The other Kavapyronas could not produce a beneficial effect on the infarct area.
\nThe study by Deng et al. examined whether late administration of GUO (guanosine) improved long-term functional recovery after stroke. Late administration of GUO improved functional recovery from day 14 after stroke when compared with the vehicle group [56].
\nGerbatin et al. evaluated the effect of guanosine on TBI-induced neurological damage. The findings showed that a single dose of guanosine (7.5 mg/kg), intraperitoneally (i.p) injected 40 min after fluid percussion injury (IPF) in rats protected them from locomotor and exploratory impairment, observed 8 h after injury, guanosine protected against neuronal death and activation of caspase 3 (protein responsible for cleaving genetic material.) This study suggests that guanosine plays a neuroprotective role in TBI and can be explored as a new pharmacological strategy [57].
\nExperimental models of ischemic stroke help our understanding of the events that occur in the ischemic and reperfused brain. One of the main developments in the treatment of acute ischemic stroke is neuroprotection.
\nDepression and stress-related disorders affect approximately 17% of the population, resulting in enormous personal suffering as well as social and economic burdens [58].
\nGuanosine is a nucleoside that has a neuroprotective effect. Current studies have analyzed the action of guanosine as an antidepressant. One study investigated the effects of guanosine on the tail suspension test (TT), open field test and adult hippocampal neurogenesis. The results suggest that the antidepressant effect of chronic guanosine use causes an increase in neuronal differentiation, suggesting that this nucleoside may be an endogenous mood modulator [59].
\nThe ability of this nucleoside to nullify acute stress-induced behavioral and biochemical changes has not been evaluated in female mice, given that depression has a greater impact on women. A study aimed at investigating the protective effect of this nucleoside against oxidative damage and stress response evaluated this using the FST (forced swimming test). The Acute Containment Stress Protocol (ARS) has been proposed as a model that triggers biochemical changes in the rat brain that may be detrimental to CNS (central nervous system) function, implicated in several psychiatric disorders, including major depression [60].
\nConsidering that the hippocampus plays a key role in mood regulation, numerous studies have evaluated whether adult hippocampal neurogenesis is altered in psychiatric disorders. Stress is a risk factor for depression that can manifest itself years after the stressful event [54].
\nBehavioral studies have shown that guanosine produces anxiolytic substances and amnesic effects. Other analyses have shown that reductions induced by hippocampal stress, cell proliferation and/or neuronal differentiation cause depressive symptoms. Deng et al. explain that hippocampal neurogenesis in humans is affected by various neurological disorders, including depression [56].
\nAccording to Duman et al. chronic administration of an antidepressant regulates neurogenesis in the hippocampus of adult rodents. Overregulation of neurogenesis could block or reverse the effects of stress on hippocampal neurons, which include downregulation of neurogenesis as well as atrophy. The possibility that the cAMP signal transduction cascade contributes to antidepressant regulation of neurogenesis is supported by previous studies and recent work [61].
\nDisturbances in hippocampal neurogenesis may be involved in the pathophysiology of depression. It has been argued that an increase in the generation of new hippocampal nerve cells is involved in the mechanism of action of antidepressants. This study, using adult Wistar rats given fluoxetine, showed that a significant behavioral effect occurred. It also pointed out that chronic antidepressant treatment increases cell proliferation as well as neurogenesis in the dentate gyrus. Neurogenesis may serve as an important parameter for examining the efficacy and mechanism of action of new drugs [61].
\nAnxiety is a diffuse mental condition manifested through unpleasant feelings of fear and apprehension without specific cause [62].
\nCurrently, the psychotherapeutic complementary treatment chosen to treat patients is through antidepressant drugs such as selective serotonin and serotonin-norepinephrine reuptake inhibitors (SSRIs), tricyclic antidepressants and benzodiazepines [63]. Due to the undesirable and destructive side effects of these drugs, including drowsiness, cognitive impairment, and symptoms of dependence and withdrawal, many patients prefer herbal remedies. Several plants with anxiolytic activity have been studied in clinical trials, and Kava (
A meta-analysis review by Pittler et al. evaluated the efficacy and safety of kava extract versus placebo for treating anxiety. Seven randomized controlled trials using
Another recent meta-analysis, conducted by Ooi et al., revealed similar results, mentioning that there is promising evidence from well-designed clinical studies suggesting Kava, particularly aqueous extracts, as an effective treatment for generalized anxiety disorder (GAD) [67]. The authors add that the effect of Kava is comparable to commonly prescribed pharmacological drugs (buspirone and opipramol), but with fewer adverse consequences.
\nIt is suggested that the progression of new treatments for psychological disorders is described in the identification of neural substrates and mechanisms underlying their etiology and pathophysiology. Adult hippocampal neurogenesis is a candidate mechanism for the etiology of depression and may be used as a substrate for antidepressant action, as it may also be important for some of the behavioral effects of antidepressants [68].
\nThe therapeutic properties of kava are supported by the six major kavalactones (dihydromethysticin, kavain, dihydrokavain, methysticin, yangonin and desmethoxyyangonin), of which kawain and dihydrokawain have more intense anxiolytic activity [69].
\nIn recent years, growing interest in research on medicinal plants and the effects of essential oils (EOs), especially for the treatment of neuropathologies, has emerged [70]. EOs (also called volatile or ethereal oils) are odorous and volatile compounds found only in 10% of the plant kingdom [71, 72, 73, 74, 75, 76].
\nSecondary metabolites present in SOs have been widely used as antibacterial, antifungal and insecticidal agents. Their chemical and biological properties, especially antioxidants, have been considered important tools for the management of various neurological disorders [76].
\nNatural antioxidants derived from herbaceous plants have demonstrated in vitro cytoprotective properties and have a long history of providing benefits to human health [70]. Evidence of oxidative stress in neuronal damage and the benefits of antioxidant therapy have elucidated the importance of eliminating free radicals as a fundamental principle for the prevention and treatment of neurological disorders [77]. In addition, OEs derived antioxidants have been considered as a complementary treatment against neuronal loss as they have the ability to counteract the activity of free radicals responsible for neurodegeneration [78], protecting against cellular stress, as outlined in Figure 2.
\nNeural cells suffer functional or sensory loss due to neurological disorders and, in addition to other environmental or genetic factors that contribute to this loss, oxidative stress is a major contributor to neurodegeneration. Therefore, excess reactive oxygen species and an unbalanced metabolism lead to a number of neurological disorders, such as Alzheimer’s disease (AD) and Parkinson’s disease (PD) [78].
\nMain identified mechanisms for the action of medicinal plant essential oils in experimental models of neurological disorders. In step A: In an experimental model of cerebral ischemia after occlusion of the common carotid artery followed by reperfusion (BCCAO/R), it was observed that occlusion in the frontal cortex caused a decrease in docosahexaenoic acid (DHA). with
Alzheimer’s disease (AD) is an age related neurodegenerative disease of the brain and this disease is characterized by a progressive deterioration of cognitive functions [79]. Oxidative stress, a detrimental factor during aging and pathologies, is involved in various neurodegenerative disorders [80, 81].
\nStudies suggest that caspase activation and apoptosis play important roles in AD neuropathogenesis [82]. Thus, SOs have been considered multi-potent agents against neurological disorders, being able to improve cognitive performance [83].
\nLavender EO has several protective properties for the nervous system, as evidenced by its effectiveness in controlling depression, anxiety, stress, and cerebral ischemia [84, 85]. Some experimental models of AD have confirmed the neuroprotective effect and cognitive improvement of lavender OS, whose properties have been attributed to its antioxidant activity [86, 87].
\nEO (100 mg/kg) presented significant protection in the cognitive deficits evaluated, where the mechanism involved seems to be by a protection against decrease in the cellular antioxidant defense system, thus avoiding the reduction of the activity of superoxide dismutase, glutathione peroxidase and protection of the increase acetylcholinesterase malondialdehyde activity. The authors also demonstrated that lavender EO and its active component linalool protect against oxidative stress, cholinergic function and Nrf2/HO-1 pathway protein expression and synaptic plasticity. Therefore, it is suggested that linalool extracted from lavender OS may be a potential agent for improving cognitive impairment, especially in AD [88].
\nOxidative stress occurs when the balance between antioxidants and reactive oxygen species (ROS) occurs negatively due to the depletion of antioxidants or the accumulation of ROS (Reactive Oxygen Species) [89]. Hydrogen peroxide (H2O2) is a major ROS and is involved in most cellular oxidative stresses [90, 91]. Several plants are considered a rich source of antioxidants because they inhibit or retard ROS-induced oxidative degradation [92, 93, 94].
\nPorres-Martínez et al. demonstrated that
Natural antioxidants present in some herbal plants are responsible for inhibiting or preventing oxidative stress, one of the agents that acts in AD, due to their ability to eliminate free radicals. The neuroprotective effect of
A pioneering study by Abuhamdah et al. showed that
Chelating agents have been reported to be effective as secondary antioxidants because they reduce the redox potential of transition metals, thereby stabilizing the oxidized form of the metal ion [96]. This seems to be one of the mechanisms involved in the antioxidant activity of some essential oils, as some of them were able to effectively chelate iron (II).
\nCerebral ischemia consists in decreased blood flow in specific areas of the brain, causing hypoxia, which leads to an insufficient supply of glucose and oxygen, the magnitude of which disturbs the development of normal brain functions [97].
\nCurrently, treatments that minimize neuronal damage after cerebral ischemia are limited, thus leading to the search for new complementary treatment therapies [98]. Terpenoids present in some essential oils constitute the largest group of secondary metabolites with neurological properties, including sedative, antidepressant and antinociceptive activities [99].
\nAnother metabolite with neuroprotective function is linalool, a monoterpene present in volatile lavender oil, responsible for important therapeutic properties [100]; its activity on nerve disorders is well documented [101, 102]. Vakili et al. demonstrated that
Neurodegenerative and neuropsychiatric diseases have multiple etiology. Multiple studies have been developed to clarify which approaches might be promising in prevention and treatment. We have targeted studies that present a neuroprotective perspective, herbal medicines and essential oils from different species of medicinal plants. These have various bioactive and phytochemical compounds with neuroprotective capacity, and also have given positive responses in studies on neurological disorders such as dementia, oxidative stress, anxiety, cerebral ischemia and oxidative toxicity. We suggest that these present a potential as agents in the treatment of neurological disorders.
\nThe English text of this paper has been revised by Sidney Pratt, Canadian, MAT (The Johns Hopkins University), RSAdip - TESL (Cambridge University).
\nThe Open Access model is applied to all of our publications and is designed to eliminate subscriptions and pay-per-view fees. This approach ensures free, immediate access to full text versions of your research.
",metaTitle:"Open Access Publishing Fees",metaDescription:"Open Access Publishing Fees",metaKeywords:null,canonicalURL:"/page/OA-publishing-fees",contentRaw:'[{"type":"htmlEditorComponent","content":"As a gold Open Access publisher, an Open Access Publishing Fee is payable on acceptance following peer review of the manuscript. In return, we provide high quality publishing services and exclusive benefits for all contributors. IntechOpen is the trusted publishing partner of over 140,000 international scientists and researchers.
\\n\\nThe Open Access Publishing Fee (OAPF) is payable only after your book chapter, monograph or journal article is accepted for publication.
\\n\\nOAPF Publishing Options
\\n\\nDuring the launching phase journals do not charge an APC, rather they will be funded by IntechOpen.
\\n\\n*These prices do not include Value-Added Tax (VAT). Residents of European Union countries need to add VAT based on the specific rate in their country of residence. Institutions and companies registered as VAT taxable entities in their own EU member state will not pay VAT as long as provision of the VAT registration number is made during the application process. This is made possible by the EU reverse charge method.
\\n\\nServices included are:
\\n\\nWhat isn't covered by the Open Access Publishing Fee?
\\n\\nIf your manuscript:
\\n\\nYour Author Service Manager will inform you of any items not covered by the OAPF and provide exact information regarding those additional costs before proceeding.
\\n\\nOpen Access Funding
\\n\\nTo explore funding opportunities and learn more about how you can finance your IntechOpen publication, go to our Open Access Funding page. IntechOpen offers expert assistance to all of its Authors. We can support you in approaching funding bodies and institutions in relation to publishing fees by providing information about compliance with the Open Access policies of your funder or institution. We can also assist with communicating the benefits of Open Access in order to support and strengthen your funding request and provide personal guidance through your application process. You can contact us at funders@intechopen.com for further details or assistance.
\\n\\nFor Authors who are still unable to obtain funding from their institutions or research funding bodies for individual projects, IntechOpen does offer the possibility of applying for a Waiver to offset some or all processing feed. Details regarding our Waiver Policy can be found here.
\\n\\nAdded Value of Publishing with IntechOpen
\\n\\nChoosing to publish with IntechOpen ensures the following benefits:
\\n\\nBenefits of Publishing with IntechOpen
\\n\\nAs a gold Open Access publisher, an Open Access Publishing Fee is payable on acceptance following peer review of the manuscript. In return, we provide high quality publishing services and exclusive benefits for all contributors. IntechOpen is the trusted publishing partner of over 140,000 international scientists and researchers.
\n\nThe Open Access Publishing Fee (OAPF) is payable only after your book chapter, monograph or journal article is accepted for publication.
\n\nOAPF Publishing Options
\n\nDuring the launching phase journals do not charge an APC, rather they will be funded by IntechOpen.
\n\n*These prices do not include Value-Added Tax (VAT). Residents of European Union countries need to add VAT based on the specific rate in their country of residence. Institutions and companies registered as VAT taxable entities in their own EU member state will not pay VAT as long as provision of the VAT registration number is made during the application process. This is made possible by the EU reverse charge method.
\n\nServices included are:
\n\nWhat isn't covered by the Open Access Publishing Fee?
\n\nIf your manuscript:
\n\nYour Author Service Manager will inform you of any items not covered by the OAPF and provide exact information regarding those additional costs before proceeding.
\n\nOpen Access Funding
\n\nTo explore funding opportunities and learn more about how you can finance your IntechOpen publication, go to our Open Access Funding page. IntechOpen offers expert assistance to all of its Authors. We can support you in approaching funding bodies and institutions in relation to publishing fees by providing information about compliance with the Open Access policies of your funder or institution. We can also assist with communicating the benefits of Open Access in order to support and strengthen your funding request and provide personal guidance through your application process. You can contact us at funders@intechopen.com for further details or assistance.
\n\nFor Authors who are still unable to obtain funding from their institutions or research funding bodies for individual projects, IntechOpen does offer the possibility of applying for a Waiver to offset some or all processing feed. Details regarding our Waiver Policy can be found here.
\n\nAdded Value of Publishing with IntechOpen
\n\nChoosing to publish with IntechOpen ensures the following benefits:
\n\nBenefits of Publishing with IntechOpen
\n\n